These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 26486371)
21. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281 [TBL] [Abstract][Full Text] [Related]
22. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337 [TBL] [Abstract][Full Text] [Related]
23. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674 [TBL] [Abstract][Full Text] [Related]
24. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Shilling V; Jenkins V Eur J Oncol Nurs; 2007 Feb; 11(1):6-15. PubMed ID: 16844416 [TBL] [Abstract][Full Text] [Related]
25. Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol. Dwek MR; Rixon L; Simon A; Hurt C; Newman S BMC Psychol; 2015 Nov; 3():43. PubMed ID: 26612628 [TBL] [Abstract][Full Text] [Related]
26. Exploratory Study of Associations Between DNA Repair and Oxidative Stress Gene Polymorphisms and Cognitive Problems Reported by Postmenopausal Women With and Without Breast Cancer. Merriman JD; Sereika SM; Conley YP; Koleck TA; Zhu Y; Phillips ML; Bertocci MA; Brufsky AM; Bender CM Biol Res Nurs; 2019 Jan; 21(1):50-60. PubMed ID: 30213196 [TBL] [Abstract][Full Text] [Related]
27. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Breckenridge LM; Bruns GL; Todd BL; Feuerstein M Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847 [TBL] [Abstract][Full Text] [Related]
28. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292 [TBL] [Abstract][Full Text] [Related]
29. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms. Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667 [TBL] [Abstract][Full Text] [Related]
30. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651 [TBL] [Abstract][Full Text] [Related]
31. Cognitive impairment associated with adjuvant therapy in breast cancer. Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037 [TBL] [Abstract][Full Text] [Related]
32. Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer. Klemp JR; Myers JS; Fabian CJ; Kimler BF; Khan QJ; Sereika SM; Stanton AL Support Care Cancer; 2018 Feb; 26(2):575-583. PubMed ID: 28849337 [TBL] [Abstract][Full Text] [Related]
33. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL Menopause; 2007; 14(6):995-8. PubMed ID: 17898668 [TBL] [Abstract][Full Text] [Related]
34. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue. Menning S; de Ruiter MB; Veltman DJ; Koppelmans V; Kirschbaum C; Boogerd W; Reneman L; Schagen SB Neuroimage Clin; 2015; 7():547-54. PubMed ID: 25844311 [TBL] [Abstract][Full Text] [Related]
35. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545 [TBL] [Abstract][Full Text] [Related]
36. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy. Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061 [TBL] [Abstract][Full Text] [Related]
37. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Brezden CB; Phillips KA; Abdolell M; Bunston T; Tannock IF J Clin Oncol; 2000 Jul; 18(14):2695-701. PubMed ID: 10894868 [TBL] [Abstract][Full Text] [Related]
38. Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer. Yao C; Rich JB; Tirona K; Bernstein LJ Psychooncology; 2017 Dec; 26(12):2261-2268. PubMed ID: 28002893 [TBL] [Abstract][Full Text] [Related]
39. Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient's Assessment of Own Functioning Inventory (PAOFI). Richardson-Vejlgaard R; Dawes S; Heaton RK; Bell MD Psychiatry Res; 2009 Aug; 169(1):70-4. PubMed ID: 19619901 [TBL] [Abstract][Full Text] [Related]
40. Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Jung MS; Cimprich B Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]